Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays

被引:159
作者
Shirota, Y [1 ]
Kaneko, S [1 ]
Honda, M [1 ]
Kawai, HF [1 ]
Kobayashi, K [1 ]
机构
[1] Kanazawa Univ, Sch Med, Dept Internal Med 1, Kanazawa, Ishikawa 9208641, Japan
关键词
D O I
10.1053/jhep.2001.23003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Genes expressed in hepatocellular carcinoma (HCC) were analyzed using cDNA microarrays to clarify gene abnormalities in HCC. mRNA was extracted from cancerous and noncancerous tissues of 10 patients with HCC, cDNA labeled with Cy5 and Cy3 fluorescence was prepared, and it was hybridized for each patient with a cDNA microarray consisting of 1,080 elements (930 unique genes). The mRNA expression rate of each element in HCC was evaluated using the level of mRNA expression in noncancerous tissue in each patient as a reference. The expression of 10 genes was enhanced 2 times or more in HCC cancerous tissue compared with noncancerous tissue in 5 or more of the 10 patients. In contrast, 9 genes were expressed at half the level or less in HCC cancerous tissue compared with noncancerous tissue. When hierarchical clustering was performed to identify genes related to clinical phenotypes of the patients, 22 genes showed changes associated with the degree of differentiation of HCC. Thirteen of these genes were transcriptional factors or tissue-specific expression proteins related to cell differentiation or development. Our present analysis clarified a number of genes that characterize HCC, This information based on examination of clinical samples is considered to be useful for clarification of the: mechanism of hepatocarcinogenesis and the diagnosis and treatment of HCC.
引用
收藏
页码:832 / 840
页数:9
相关论文
共 65 条
  • [1] Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma
    Abou-Shady, M
    Baer, HU
    Friess, H
    Berberat, P
    Zimmermann, A
    Graber, H
    Gold, LI
    Korc, M
    Büchler, MW
    [J]. AMERICAN JOURNAL OF SURGERY, 1999, 177 (03) : 209 - 215
  • [2] Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver
    Aihara, T
    Noguchi, S
    Miyoshi, Y
    Nakano, H
    Sasaki, Y
    Nakamura, Y
    Monden, M
    Imaoka, S
    [J]. HEPATOLOGY, 1998, 28 (01) : 86 - 89
  • [3] INSULIN-LIKE GROWTH-FACTOR-2 AND INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN-2 EXPRESSION IN HEPATOBLASTOMA
    AKMAL, SN
    YUN, K
    MACLAY, J
    HIGAMI, Y
    IKEDA, T
    [J]. HUMAN PATHOLOGY, 1995, 26 (08) : 846 - 851
  • [4] CLONING AND FUNCTIONAL-ANALYSIS OF SPLICED ISOFORMS OF HUMAN NUCLEAR FACTOR I-X - INTERFERENCE WITH TRANSCRIPTIONAL ACTIVATION BY NFI CTF IN A CELL-TYPE-SPECIFIC MANNER
    APT, D
    LIU, YC
    BERNARD, HU
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (19) : 3825 - 3833
  • [5] The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
    Arenberg, DA
    Polverini, PJ
    Kunkel, SL
    Shanafelt, A
    Hesselgesser, J
    Horuk, R
    Strieter, RM
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (05) : 554 - 562
  • [6] Brewster JL, 2000, GENESIS, V26, P271, DOI 10.1002/(SICI)1526-968X(200004)26:4<271::AID-GENE90>3.0.CO
  • [7] 2-E
  • [8] GRO-BETA, GRO-ALPHA -C-X-C- CHEMOKINE, IS AN ANGIOGENESIS INHIBITOR THAT SUPPRESSES THE GROWTH OF LEWIS-LUNG-CARCINOMA IN MICE
    CAO, YH
    CHEN, C
    WEATHERBEE, JA
    TSANG, M
    FOLKMAN, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) : 2069 - 2077
  • [9] Chao Y, 1998, CANCER RES, V58, P985
  • [10] Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle
    Chiao, PJ
    Hunt, KK
    Grau, AM
    Abramian, A
    Fleming, J
    Zhang, W
    Breslin, T
    Abbruzzese, JL
    Evans, DB
    [J]. CELL AND MOLECULAR BIOLOGY OF PANCREATIC CARCINOMA: RECENT DEVELOPMENTS IN RESEARCH AND EXPERIMENTAL THERAPY, 1999, 880 : 31 - 37